Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.71B |
| Enterprise Value | 6.2B |
| P/E Ratio | 16.6 |
| PEG Ratio | 0.16 |
| Price/Sales Ratio | 4.21 |
| Price/Book Ratio | 1.68 |
| Enterprise/Revenue | 3.85 |
| Enterprise/EBITDA | 13.83 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.25 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 1.06B |
| Revenue/Share | 3.8 |
| Gross Profit | 762.92M |
| EBITDA | 236.08M |
| Net Income | 244.37M |
| Diluted EPS | 0.76 |
Balance Sheet
| Total Cash | 1.48B |
| Total Cash/Share | 4.67 |
| Total Debt | 143.12M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 4.67 |
| Book Value Per Share | 9.44 |
Price History
| 52-Week Change | -22.63 |
| 52-Week High | 28 |
| 52-Week Low | 17.1 |
| Moving Average 50 Days | 20.5 |
| Moving Average 200 Days | 21.15 |
Statistics
| Average Volume | 574,370 |
| Shares Outstanding | 322.06M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.31 |
| Trailing Annual Dividend Yield | 1.94 |
| Payout Ratio | 0.24 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
